{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:10:16Z","timestamp":1787501416942,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Cephalon, Inc."},{"name":"Cephalon, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jpainsymman.2010.02.009","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T04:41:01Z","timestamp":1278045661000},"page":"747-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of\u00a0Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month Study"],"prefix":"10.1016","volume":"40","author":[{"given":"Perry G.","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.02.009_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pain.2004.03.006","article-title":"Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000","volume":"109","author":"Caudill-Slosberg","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpain.2005.11.006","article-title":"Opioid prescriptions by U.S. primary care physicians from 1992 to 2001","volume":"7","author":"Olsen","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/AJP.0b013e31802b582f","article-title":"Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry","volume":"23","author":"Portenoy","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib4","author":"American Academy of Pain Medicine and the American Pain Society"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Opioid treatment guidelines. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib6","author":"The Federation of State Medical Boards of the United States"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib7","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Phys"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpain.2008.10.007","article-title":"Research gaps on the use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.ajp.0000210932.27945.4a","article-title":"A\u00a0randomized placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer","volume":"22","author":"Portenoy","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1191\/026921601678576220","article-title":"Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice","volume":"15","author":"Zeppetella","year":"2001","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jpain.2006.02.003","article-title":"Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain","volume":"7","author":"Portenoy","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00137696-200604010-00001","article-title":"Fentanyl effervescent buccal tablets","volume":"4","author":"Durfee","year":"2006","journal-title":"Am J Drug Deliv"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1358\/dot.2008.44.1.1178469","article-title":"Fentanyl buccal tablet","volume":"44","author":"Messina","year":"2008","journal-title":"Drugs Today"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib14","first-page":"327","article-title":"Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain","volume":"5","author":"Slatkin","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/030079906X162818","article-title":"Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clinthera.2007.04.007","article-title":"Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study","volume":"29","author":"Simpson","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction","volume":"146","author":"Martell","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib19","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1097\/00007632-200011150-00017","article-title":"The Oswestry Disability Index","volume":"25","author":"Fairbank","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib20","series-title":"POMS manual profile of mood states","author":"McNair","year":"1992"},{"issue":"Suppl","key":"10.1016\/j.jpainsymman.2010.02.009_bib21","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1741-7015-5-39","article-title":"Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine","volume":"5","author":"Kalso","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1185\/030079906X162692","article-title":"A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain","volume":"23","author":"Katz","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"4 Suppl. 1","key":"10.1016\/j.jpainsymman.2010.02.009_bib25","first-page":"S58","article-title":"Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia","volume":"10","author":"Murphy","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib26","first-page":"298","article-title":"Long-term management of noncancer pain with transdermal therapeutic system-fentanyl","volume":"4","author":"Mystakidou","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5055\/jom.2006.0025","volume":"2","author":"Rauck","year":"2006","journal-title":"J Opioid Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","article-title":"Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial","volume":"136","author":"Russell","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.02.009_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2008.10.009","article-title":"Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410003908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410003908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:06Z","timestamp":1760130246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392410003908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0885392410003908"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.009","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of\u00a0Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}